Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendationMatthias Gückenberger, Piet Ost, Yolande Lievens et al.|The Lancet Oncology|2020Cited by 1.1k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upSibylle Loibl, Nadia Harbeck, Prudence A. Francis et al.|Annals of Oncology|2023Cited by 830
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision makingNicolaus Andratschke, Carsten Nieder, Jonas Willmann et al.|The Lancet Oncology|2022Cited by 192
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platformJonas Willmann, Nicolaus Andratschke, Ane Appelt et al.|Radiotherapy and Oncology|2023Cited by 72
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?Federica Miglietta, Valentina Guarneri, Luca Visani et al.|Cancer Treatment Reviews|2022Cited by 22